309 related articles for article (PubMed ID: 26423152)
1. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
[TBL] [Abstract][Full Text] [Related]
2. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
3. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
Mahne AE; Mauze S; Joyce-Shaikh B; Xia J; Bowman EP; Beebe AM; Cua DJ; Jain R
Cancer Res; 2017 Mar; 77(5):1108-1118. PubMed ID: 28122327
[TBL] [Abstract][Full Text] [Related]
4. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
Coe D; Begom S; Addey C; White M; Dyson J; Chai JG
Cancer Immunol Immunother; 2010 Sep; 59(9):1367-77. PubMed ID: 20480365
[TBL] [Abstract][Full Text] [Related]
5. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
Richards DM; Marschall V; Billian-Frey K; Heinonen K; Merz C; Redondo Müller M; Sefrin JP; Schröder M; Sykora J; Fricke H; Hill O; Gieffers C; Thiemann M
J Immunother Cancer; 2019 Jul; 7(1):191. PubMed ID: 31324216
[TBL] [Abstract][Full Text] [Related]
6. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Treg cells/T effector function by GITR signaling is context-dependent.
Ephrem A; Epstein AL; Stephens GL; Thornton AM; Glass D; Shevach EM
Eur J Immunol; 2013 Sep; 43(9):2421-9. PubMed ID: 23722868
[TBL] [Abstract][Full Text] [Related]
9. GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.
Schaer DA; Budhu S; Liu C; Bryson C; Malandro N; Cohen A; Zhong H; Yang X; Houghton AN; Merghoub T; Wolchok JD
Cancer Immunol Res; 2013 Nov; 1(5):320-31. PubMed ID: 24416730
[TBL] [Abstract][Full Text] [Related]
10. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells.
Igarashi H; Cao Y; Iwai H; Piao J; Kamimura Y; Hashiguchi M; Amagasa T; Azuma M
Biochem Biophys Res Commun; 2008 May; 369(4):1134-8. PubMed ID: 18346459
[TBL] [Abstract][Full Text] [Related]
11. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
[TBL] [Abstract][Full Text] [Related]
12. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice.
Liao G; Detre C; Berger SB; Engel P; de Waal Malefyt R; Herzog RW; Bhan AK; Terhorst C
Gastroenterology; 2012 Mar; 142(3):582-591.e8. PubMed ID: 22155173
[TBL] [Abstract][Full Text] [Related]
14. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
[TBL] [Abstract][Full Text] [Related]
15. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
16. Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells.
Carrier Y; Whitters MJ; Miyashiro JS; LaBranche TP; Ramon HE; Benoit SE; Ryan MS; Keegan SP; Guay H; Douhan J; Collins M; Dunussi-Joannopoulos K; Medley QG
Eur J Immunol; 2012 Jun; 42(6):1393-404. PubMed ID: 22678896
[TBL] [Abstract][Full Text] [Related]
17. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells.
Liao G; Nayak S; Regueiro JR; Berger SB; Detre C; Romero X; de Waal Malefyt R; Chatila TA; Herzog RW; Terhorst C
Int Immunol; 2010 Apr; 22(4):259-70. PubMed ID: 20139172
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.
Ronchetti S; Ricci E; Petrillo MG; Cari L; Migliorati G; Nocentini G; Riccardi C
J Immunol Res; 2015; 2015():171520. PubMed ID: 25961057
[TBL] [Abstract][Full Text] [Related]
19. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
[TBL] [Abstract][Full Text] [Related]
20. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
Lu L; Xu X; Zhang B; Zhang R; Ji H; Wang X
J Transl Med; 2014 Feb; 12():36. PubMed ID: 24502656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
